Objective-The genetic program underlying lymphatic development is still incompletely understood. This study aims to dissect the role of receptor tyrosine kinase with immunoglobulin-like and EGF (epidermal growth factor)-like domains 1 (Tie1) and Tie2 in lymphatic formation using genetically modified mouse models. Approach and Results-We generated conditional knockout mouse models targeting Tie1, Tie2, and angiopoietin-2 in this study. Tie1 ΔICD/ΔICD mice, with its intracellular domain targeted, appeared normal at E10.5 but displayed subcutaneous edema by E13.5. Lymph sac formation occurred in Tie1 ΔICD/ΔICD mice, but they had defects with the remodeling of primary lymphatic network to form collecting vessels and valvulogenesis. Consistently, induced deletion of Tie1-ICD postnatally using a ubiquitous Cre deleter led to abnormal lymphangiogenesis and valve formation in Tie1-ICD iUCKO/− mice. In comparison with the lymphatic phenotype of Tie1 mutants, we found that the diameter of lymphatic capillaries was significantly less in mice deficient of angiopoietin-2, besides the disruption of collecting lymphatic vessel formation as previously reported. There was also no lymphedema observed in Ang2 −/− mice during embryonic development, which differs from that of Tie1 ΔICD/ΔICD mice. We further investigated whether Tie1 exerted its function via Tie2 during lymphatic development. To our surprise, genetic deletion of Tie2 (Tie2 iUCKO/− ) in neonate mice did not affect lymphatic vessel growth and maturation.
T he formation of a functional lymphatic system, including initial lymphatics and collecting vessels with smooth muscle cell (SMC) coverage and intraluminal valves, is crucial for maintaining tissue fluid homeostasis. [1] [2] [3] [4] The key events of lymphatic development include lymphatic endothelial cell (LEC) differentiation, 5 lymphovenous separation, 6, 7 the formation of primary lymphatic network, 8, 9 followed by the remodeling of the network to form a mature lymphatic system. The process of lymphatic remodeling and maturation involves the recruitment of peri-lymphatic SMCs, as well as valve development, in collecting vessels. [10] [11] [12] [13] [14] The cellular and molecular mechanism underlying the events is still incompletely understood.
Tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (Tie1) is a member of receptor tyrosine kinase family with a high degree of homology with Tie2. They are differentially required during vascular development. Tie2-mediated signals are crucial for the endothelial cell survival, maturation, and maintenance of blood vessel integrity. [15] [16] [17] However, Tie2 expression is inhibited in LECs with high expression of prospero homeobox protein 1 (Prox1). 18, 19 In contrast, Tie1 is coexpressed with Prox1 by LECs. 20 Mice null for Tie1 exhibit edema and hemorrhage with microvessels. 16, 20, 21 Deletion of Tie1 was reported to result in abnormal lymphangiogenesis, 20, 22 including lymphatic overgrowth at initial stage but LEC apoptosis later with disrupted lymphatic network formation during embryonic development. 20 Both angiopoietin-1 (Ang1) and Ang2 are ligands for Tie2 but do not bind to Tie1. It has been shown that Ang1 could induce Tie1 phosphorylation in cultured cells when Tie1 is coexpressed with Tie2. 23 In vitro biochemical analysis has shown that Tie1 could heterodimerize with Tie2. 24 Therefore, Tie1 activation may be initiated indirectly by ligands binding to Tie2 in endothelial cells. However, there is also evidence suggesting that Tie1 may modulate blood vessel morphogenesis by downregulating Tie2-mediated signaling. 25 Ang1-deficient mice die before the lymphatic development. 26 However, Ang2 knockout mice show normal blood vascular development during embryogenesis 27 but display abnormal recruitment of SMCs with lymphatic capillaries and defects with collecting lymphatic vessel formation and valve development. 27, 28 Interestingly, the lymphatic phenotype in Ang2 null mice could be rescued in the Ang1 knockin mice. 27 In spite of these findings, it is still poorly understood about how Tie1 and Tie2 are involved in the process of lymphatic formation and remodeling. To investigate further the role of Tie1-and Tie2-mediated signals in lymphatic development, we generated conditional knockout mouse models targeting Tie1, Tie2, and Ang2. Findings from this study indicate that Tie1 is important in the process of remodeling primary lymphatic network to form collecting vessels and valvulogenesis, which is independent of Tie2.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Generation of Conditional Tie1-ICD Flox Mice
To investigate the function of Tie1 intracellular kinase domain in lymphatic development, we generated a conditional knockout model with its exon 15 and exon 16 flanked by loxP sites (Tie1 Flox , Figure 1A ). The 2 exons encode part of Tie1 intracellular domain (ICD) immediately after the transmembrane domain. To examine the floxed allele, we crossed Tie1-ICD Flox/ Flox with EIIa-Cre mice to excise exon 15 and 16. Transcripts encoding the truncated Tie1 lacking the ICD (Tie1 ∆ICD ) were detected by reverse transcription polymerase chain reaction ( Figure 1B ), and its protein was confirmed by Western blot analysis ( Figure 1C ). The truncated Tie1 consists of the extracellular and transmembrane region plus a small intracellular fragment (ATCILLSNTPPMETYWTS). As shown in Figure 1C , the size of the truncated Tie1 (Tie1 ΔICD ) is ≈90 kDa (817 amino acids). We noticed that the expression level of Tie1 ΔICD decreased dramatically in Tie1 ΔICD/ΔICD mice compared with that of wild-type mice. This may be because of the nonsense-mediated mRNA decay, which is triggered when ribosomes encounter the premature translation-termination codon. 29 vascular endothelial cells costained for platelet endothelial cell adhesion molecule 1 ( Figure 1D ; E10.5, embryonic day 10.5) and also in LECs shown in the following figures. Interestingly, Tie1 ΔICD/ΔICD mice displayed less severe vascular phenotypes in comparison with that of Tie1 complete knockout mice 16, 20, 21 and survived to the later stage during embryonic development.
Approximately two thirds of Tie1 ΔICD/ΔICD mice of 10 litters were alive at E18.5 (total 69 embryos; Tie1 ΔICD/ΔICD : 17.39%; Tie1 +/ΔICD : 55.07%; Tie1 +/+ : 27.54%). Tie1 ΔICD/ΔICD mice could be born alive, but none of them survived.
Abnormal Formation of Primary Lymphatic Network in Tie1 ΔICD/ΔICD Mice
We then analyzed the vascular formation of Tie1 ΔICD/ΔICD mice at different stages of embryogenesis. Mice homozygous for Tie1-ICD deletion appeared normal at E10.5, with the proper formation of blood vessels ( Figure 1D ) but developed back edema by E13.5 ( Figure 1E ). However, lymph sac formation occurred without obvious abnormality in Tie1 ΔICD/ΔICD mice. Further analysis of LEC proliferation by BrdU (5-bromo-2'-deoxyuridine) labeling showed that there was no significant difference in LEC proliferation between Tie1 ΔICD/ΔICD and control mice at E12.5 (Figure 2A and 2B Figure 2C ). Furthermore, edema in Tie1 ΔICD/ΔICD mice became more severe at E15.5. By whole-mount immunostaining, we showed that the lymphatic network became disorganized in Tie1 ΔICD/ΔICD mice as shown in Figure 2D .
There was a significant increase in the number of abnormal lymphatic connections in Tie1 ΔICD/ΔICD mice (per grid, white arrow in Figure 2D ; 2.08±0.93, n=6) compared with Tie1 +/ΔICD (0.27±0.14, n=6; P=0.0008) and wild-type control (0.19±0.14, n=4; P=0.0042). Also we observed isolated lymphatic fragments in the skin of Tie1 ΔICD/ΔICD mice (per grid, arrowhead in Figure 2D ; Tie1 ΔICD/ΔICD : 0.44±0.29, n=6), which were rarely observed in the heterozygous (0.07±0.08, n=6; P=0.0131) and wild-type control (0.05±0.07, n=4; P=0.0321). Consistently, we observed a decrease of Prox1 positive LEC number in Tie1 ΔICD/ΔICD mutants (305.72±64.31 cells/grid, n=6) in comparison with that of heterozygous (440.91±65.33 cells/grid, n=6; P=0.0074) and wild-type control at E15.5 (438.80±55.73 and total LECs (C) in the tissue sections across the lymph sac region of homozygous Tie1 △ICD/△ICD , heterozygous Tie1 +/△ICD , and wild-type mice at E12.5. There is no significant difference in LEC proliferating index between Tie1 △ICD/△ICD and control mice in spite of a trend toward less LECs in Tie1 mutant embryos. D, Whole-mount immunostaining for lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1; green) and Prox1 (red) with the back skin of E15.5 embryos. Note that deletion of Tie1-ICD disrupts proper formation of lymphatic network compared with that of control mice (white arrowhead points to an isolated lymphatic fragment and arrows point to abnormal lymphatic connection). E and F, Quantification of LECs (Prox1 + ) and lymphatic branch points in the skin of homozygous Tie1 △ICD/△ICD , heterozygous Tie1 +/△ICD , and wild-type mice. Scale bar, 25 μm in A and 200 μm in D.
cells/grid, n=4; P=0.0138; Figure 2E ). There was no significant difference in lymphatic branch points in skin tissue at this stage (Tie1 ΔICD/ΔICD : 16.96±5.27 points/grid, n=6; Tie1 +/ΔICD : 18.27±3.27 points/grid, n=6; wild-type Tie1 +/+ : 17.26±2.61 points/grid, n=4; Figure 2F ). Interestingly, at a later stage of embryonic development (E17.5), Tie1 ΔICD/ΔICD mutants appeared swollen with increased lymphatic vessel branching points and diameter ( Figure I in the online-only Data Supplement) compared with wild-type and heterozygous mice. This may be secondary to the subcutaneous edema. A similar observation was also made with lymphatic capillaries in the intestine (Shang Z, He Y, unpublished data, 2014).
Failure of Collecting Lymphatic Vessel Formation and Valvulogenesis in Tie1 ∆ICD/∆ICD Mice
We found that Tie1 was highly expressed in lymphatic valves in embryos ( Figure 3A ) and also in postnatal mice ( Figure 3B ). As shown in Figure 3C , white arrow points to one collecting lymphatic vessel with strong staining for Prox1 but weak for lymphatic vessel endothelial hyaluronan receptor 1 in the heterozygous Tie1 +/ΔICD mice (E15.75). However, the remodeling of lymphatic capillaries to form collecting vessels did not occur in Tie1 ΔICD/ΔICD mice ( Figure 3C ). Lack of collecting lymphatic formation in Tie1 mutant mice was further confirmed by Prox1 staining of back skin at E18.5 ( Figure 3D ). There were also no lymphatic valves detected in Tie1 ΔICD/ΔICD mice as visualized by integrin-α9 staining ( Figure 3D ). Consistent with the observation with mesentery lymphatic development, 10, 12, 31 the process of collecting vessel formation and valvulogenesis starts at a similar time in skin. As shown in Figure II in the online-only Data Supplement, the valve morphogenesis started with the formation of LEC clusters, which was first detected at E15.5 (arrow). Valve forming region with condensed LECs became more obvious by E16.5 (arrow). LEC condensation was not observed in Tie1 ΔICD/ΔICD mice. Similar defects with collecting lymphatic vessel formation and valve development were also observed in the mesentery of intestine of Tie1 ΔICD/ΔICD mice ( Figure 4A -4C).
Requirement of Tie1 in Postnatal Lymphatic Growth and Maturation
To examine the role of Tie1 in postnatal lymphangiogenesis, we generated the doubly transgenic mice (Tie1-ICD Flox/− ;UBC-CreERT2) by mating Tie1-ICD Flox mice with the transgenic mouse line ubiquitously expressing CreERT2 (a Cre recombinase fused to a mutant estrogen ligand-binding domain,UBC-CreERT2). 32 Tie1 deletion was induced by the intragastric injection of tamoxifen into new-born pups from postnatal day 1 to 3, and Tie1-ICD Flox/+ ;UBC-CreERT2 mice were used as control. Mice were analyzed at P7 or at a later stage. As shown in Figure 5A , Tie1-ICD iUCKO/− mice displayed defective formation of lymphatic network in tail skin. Tie1-ICD deletion efficiency is shown in Figure 5B . By quantification analysis, we showed that there was a significant decrease in lymphatic ring structure in tail skin of Tie1 mutant mice compared with that of control mice (Tie1-ICD iUCKO/− : 7.75±3.04 lymphatic ring/grid, n=3; Tie1-ICD Flox/− : 31.38±2.49 lymphatic ring/ grid, n=4; P<0.0001; Figure 5F ). The abnormal lymphatic network in Tie1-ICD iUCKO/− mice was validated by fluorescence microlymphography using fluorescein isothiocyanate-dextran ( Figure 5C ), and the development of feet edema was also observed in Tie1 mutant mice ( Figure 5D ). We further demonstrated that lymphatic vessels became sparse and disorganized in the ear skin of Tie1-ICD iUCKO/− mice ( Figure 5E ). There was a significant decrease of lymphatic density in Tie1-ICD mutants compared with control mice (Tie1-ICD iUCKO/− : 31.4±6.62×10 4 μm 2 /grid, n=3; Tie1-ICD iUCKO/+ : 42.83±3.09×10 4 μm 2 /grid, n=4; P=0.0268; Figure 5G ). To examine collecting lymphatics and valves in Tie1-ICD iUCKO/− mice, we performed immunostaining for platelet endothelial cell adhesion molecule 1, lymphatic vessel endothelial hyaluronan receptor 1, and integrin-α9 with ear skin from the mutant and control mice. We found that lymphatic vessels became sparse and valves in the precollecting lymphatic vessels were not properly formed in the ventral side of ear skin ( Figure 6A ). There was a significant decrease of lymphatic valves in Tie1-ICD iUCKO/− mutants (2.13±0.74 valves/grid, n=4) in comparison with that of control mice (6.14±0.68 valves/grid, n=5, P<0.0001). In the dorsal side of ear skin, valves in the large collecting vessels were formed in Tie1-ICD iUCKO/− mice ( Figure 6B ). However, the collecting lymphatics in Tie1-ICD iUCKO/− mice showed strong staining with lymphatic vessel endothelial hyaluronan receptor 1, which did not occur in those of control mice ( Figure 6B ). This suggests that the deletion of Tie1 postnatally may impair the maturation of collecting lymphatic vessels.
Distinct Lymphatic Abnormality in Ang2 Null Mice
To explore the connection between Tie1 and Ang2 in lymphatic development, we generated a conditional knockout mouse model targeting Ang2, with its exon 3 flanked by loxP sites (Ang2 Flox , Figure 7A ). To examine the floxed allele, we crossed Ang2 Flox/Flox with EIIa-Cre mice to excise exon 3, and there was no Ang2 expression detected in Ang2 null mice by Western blot analysis ( Figure 7B ). In addition to the defective formation of collecting lymphatic vessels as previously reported, 27, 28 we found that the diameter of lymphatic vessels was altered in Ang2 −/− mice compared with that of control mice (Figure 7C , 7D, and 7G). By quantification, there was a significant decrease in lymphatic vessel diameter (Ang2 −/− : 12.97±0.93 μm, n=4; Ang2 +/− : 18.51±0.83 μm, n=4; P=0.0001) and LEC number in vessel wall (Ang2 −/− : 6.90±0.84 LECs/100 μm lymphatic vessel, n=4; Ang2 +/− : 9.56±0.76 LECs/100 μm lymphatic vessel; P=0.0033) of Ang2 −/− mice compared with control mice at E18.5 ( Figure 7D-7F ). Consistent with previous findings, 28 there was abnormal SMC recruitment with lymphatic capillaries ( Figure III in the online-only Data Supplement) and no formation of lymphatic valves in Ang2 null mice as visualized by integrin-α9 staining ( Figure 7G ). Similar observations with defects in collecting vessel formation were also made in the mesentery of intestine ( Figure III in the online-only Data Supplement). However, there was no lymphedema observed in Ang2 null mice during embryogenesis in spite of the lymphatic abnormalities, which differed from those of Tie1 ΔICD/ΔICD mice. 
Normal Lymphatic Development in Tie2-Deficient Mice
We found that Tie2 was weakly expressed in lymphatic vessels ( Figure 8A ). To investigate the biological role of Tie2 in lymphatic vessel formation, we generated a conditional knockout mouse model with exon 1 of Tie2 gene flanked by loxP sites (Tie2 Flox , Figure 8B ). We crossed Tie2 Flox/Flox with EIIa-Cre mice to excise exon 1 and found that Tie2 null mice died by E10.5 as previously reported. To study the role of Tie2 in lymphangiogenesis, we used the UBC-CreERT2 mouse line to generate the doubly transgenic mice (Tie2 Flox/− ;UBC-CreERT2), and Tie2 Flox/+ ;UBC-CreERT2 mice were used as control. Tie2 deletion was induced by intragastric injection of tamoxifen into new-born pups as described above, and the deletion efficiency was shown in Figure 8C . Surprisingly, there were no obvious defects observed with lymphatic development in Tie2 iUCKO/− mice ( Figure 8D and 8E ). Furthermore, lymphatic valves (white arrow) in precollectors and large collecting vessels also formed normally in Tie2 mutants compared with those of control mice ( Figure 8G ).
Discussion
We have shown in this study that the remodeling of primary lymphatic network to form collecting vessels including valve development was disrupted in mice homozygous for Tie1 mutation (Tie1 ΔICD/ΔICD ), in addition to the abnormal lymphangiogenic growth as previously reported. 20, 22 Although mice null for Ang2 also displayed defective formation of lymphatic vessels, the phenotypes were different from that of Tie1 ΔICD/ΔICD mice, including thinner lymphatic capillaries with abnormal SMC coverage and lack of lymphedema. We have further demonstrated that postnatal deletion of Tie2 (Tie2 iUCKO/− ) did not affect lymphatic growth. Therefore, independent of Tie2, Tie1 is important in the process of lymphatic remodeling and maturation, which differs from that of Ang2 deficiency.
It is worth pointing out that Tie1 allele (Tie1-ICD Flox ) of the mutant mice developed in this study appeared to be hypomorphic with reduced expression of Tie1 ΔICD , which is similar to the reported hypomorphic Tie1 neo/neo mice. 20 In spite of the low level of Tie1 ΔICD expression, we noticed that Tie1 ΔICD/ΔICD mice displayed less severe vascular phenotype in comparison with that of Tie1 null mice. 16, 20, 21 It is, therefore, possible that Tie1 ΔICD retains the function of Tie1 and that the lethality of Tie1 ΔICD/ΔICD mice may result from the low expression level of Tie1 ∆ICD . It remains to be validated whether the biological function of Tie1 relies on its intracellular kinase domain. Furthermore, we showed that the formation of lymph sac occurred in Tie1 ΔICD/ΔICD mice, but LEC number decreased in embryo sections (E12.5), as well as whole-mount skin tissues (E15.5) in Tie1 mutants, compared with that of control mice. This is also consistent with results from our postnatal study where induced deletion of Tie1-ICD resulted in decreased lymphatic density as shown in Figure 5 . Furthermore, lymphatic network was disorganized in Tie1 mutants during embryonic and postnatal development. The findings imply an important role of Tie1 in the formation and maintenance of lymphatic integrity. In contrast to the previous reports, 20 we did not detect a significant difference in LEC proliferating index between Tie1 ΔICD/ΔICD and control mice at E12.5. However, we did observe that there was an increase in the diameter and density of lymphatic vessels in Tie1 ΔICD/ΔICD mice at later stage of embryonic development (E17.5). It is likely that this may be secondary to tissue edema resulting from increased vascular leakage and abnormal lymphatic draining in Tie1 mutants.
Although Ang2-deficient mice had abnormal lymphatic development, as also shown by other researchers, 27, 28 we found that Ang2 null mice and Tie1 mutants displayed distinct lymphatic defects. Consistent with previous reports, 28 we observed that there was abnormal coverage of SMC with lymphatic capillaries in Ang2-deficient mice ( Figure III in the online-only Data Supplement) but not in Tie1 mutants. Interestingly we also showed that the diameter of lymphatic capillaries and the number of LECs in the vessel wall were significantly less in Ang2 −/− mice than those of littermate controls. However, in spite of the lymphatic defects, there were no lymphedema observed in Ang2 null mice during embryonic development. Furthermore, although it has been shown that genetic insertion of Ang1 cDNA into Ang2 locus in the knockin model can rescue the lymphatic defects of Ang2 null mice, 27 it is unclear how Ang1 exerts such an effect on LECs, where Tie2 is lowly expressed. Findings from this study have further demonstrated that induced deletion of Tie2 in neonatal mice did not affect lymphatic development. Because there is no direct interaction of Ang1 or Ang2 with Tie1, it remains to be explored how Tie1 and angiopoietins exert their function, independent of Tie2, during the lymphatic remodeling and valvulogenesis.
The formation of collecting lymphatics involves the fusion of lymphatic capillaries into larger ones containing intraluminal valves. 33 In our previous study, we showed that integrin-α9-positive valve structures were observed mainly at sites where 2 lymphatic vessels converge. 13 It is likely that valve morphogenesis may occur simultaneously during the lymphatic remodeling to form the collecting lymphatics and that the pre-existing endothelium of fused lymphatic Note that Tie2 is weakly expressed in lymphatic vessels in comparison with its high expression in blood vessels. B, Tie2 Flox -targeting construct. Two loci of crossover in P1 bacteriophage (loxP) sites (red triangles) together with the neo cassette flanked by 2 FRT sites (blue triangles) were introduced into the 5′ region upstream of transcription initiation site and intron 1, respectively, to flank exon 1 of Tie2. Founders were mated with Cre-or FLP-expressing mice to generate models with the modified allele. C, Western blot analysis of Tie2 expression in the lung of Tie2 iUCKO/− and control mice. D and E, Analysis of lymphatic vessels by immunostaining for platelet endothelial cell adhesion molecule 1 (PECAM1; red), lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1; green), and Tie2 (blue) in the tail skin of Tie2 iUCKO/− and control mice (P7, postnatal day 7). There was no obvious difference in the formation of collecting lymphatic vessels (D, white arrow; arrowhead in D points to one lymphatic vessel with Tie2 staining) and lymphatic network (E) between Tie2 mutant and control mice. F and G, Analysis of lymphatic vessels and valve formation by immunostaining for PECAM1 or LYVE1 (green) and integrin-α9 (red) in the ear skin of Tie2 iUCKO/− and control mice (3-week-old). Note that lymphatic valves (white arrow) in precollectors and large collecting vessels form normally in Tie2 mutants compared with those of control mice. Scale bar, 25 μm in A and 100 μm in D, E, and G.
capillaries may provide an important base during valvulogenesis. Although the mechanism underlying the formation of collecting lymphatics and valves awaits further investigation, one interesting observation is that primary lymphatic network exerts fluid draining function even before the establishment of a mature lymphatic network containing collecting lymphatics with intraluminal valves. This has been shown in genetically modified mouse models where lymphedema occurs because of the defective formation of primary lymphatic network, as shown in Vegfr3 ΔLBD/ΔLBD or Vegfr3 TKmut/TKmut mice, 8 at a stage (eg, E13.5) when collecting lymphatics has not been formed. The formation of valved collecting lymphatic vessels initiates at approximately E15.5 during murine embryonic development as shown in this study ( Figure 3C ; Figure II in the online-only Data Supplement) and also by other researchers. [10] [11] [12] 31 It is, therefore, reasonable to speculate that the initial lymph flow in primary lymphatic network plays an important role in lymphatic network remodeling. It has been found that various genes can be regulated by shear stress in LECs 12 and BECs (blood vascular endothelial cells), 34, 35 including Tie1. 36, 37 Tie1 is widely expressed by endothelial cells of both blood vascular and lymphatic vessels during embryonic development. However, it is downregulated postnatally in blood vasculature, and constitutive expression of Tie1 is only maintained in selected areas of the adult vasculature 38 or induced in areas constantly exposed to disturbed flow, such as at vascular branching points. 36 Interestingly, consistent with previous findings, 39 we found that Tie1 was highly expressed by LECs, particularly in lymphatic valves. The mechanism of flow inducible Tie1 in lymphatic remodeling and maturation is still to be investigated. Furthermore, although several other factors have been reported to participate in the process of lymphatic valve development, 3, 4 it is still to be examined whether Tie1 and the previously reported genes are directly required for valve formation or the observed disruption of valvulogenesis may be secondary to the defective formation of collecting lymphatic vessels. It is also interesting to find out how these factors coordinate to control collecting vessel formation and maturation and whether they work in the same pathway or in different pathways controlling specific cellular programs.
In summary, we show in this study that Tie1, independent of Tie2, plays important roles in lymphatic formation, remodeling, and valvulogenesis. Although the detailed molecular mechanism underlying the process awaits further investigation, it is interesting to speculate that shear stress inducible Tie1 may participate in sensing dynamic changes of fluid flow when the lymph circulation is established during embryogenesis. Studies along the line will provide further insights into the cellular and molecular events responsible for lymphatic development.
